83
哈药集团制药总厂 HARBIN HARBIN HARBIN HARBIN PHARMACEUTICAL PHARMACEUTICAL PHARMACEUTICAL PHARMACEUTICAL GROUP GROUP GROUP GROUP CO., CO., CO., CO., LTD LTD LTD LTD General General General General Pharm. Pharm. Pharm. Pharm. Factory Factory Factory Factory CTD CTD CTD CTD Module Module Module Module 3.2.S 3.2.S 3.2.S 3.2.S for for for for Sterile Sterile Sterile Sterile Cefoperazone Cefoperazone Cefoperazone Cefoperazone Sodium Sodium Sodium Sodium THE THE THE THE COMMON COMMON COMMON COMMON TECHNICAL TECHNICAL TECHNICAL TECHNICAL DOCUMENT DOCUMENT DOCUMENT DOCUMENT 3.2.S 3.2.S 3.2.S 3.2.S FOR FOR FOR FOR THE THE THE THE REGISTRATION REGISTRATION REGISTRATION REGISTRATION OF OF OF OF PHARMACEUTICALS PHARMACEUTICALS PHARMACEUTICALS PHARMACEUTICALS FOR FOR FOR FOR HUMAN HUMAN HUMAN HUMAN USE: USE: USE: USE: Sterile Sterile Sterile Sterile Cefoperazone Cefoperazone Cefoperazone Cefoperazone Sodium Sodium Sodium Sodium Open Open Open Open part part part part HARBIN HARBIN HARBIN HARBIN PHARMACEUTICAL PHARMACEUTICAL PHARMACEUTICAL PHARMACEUTICAL GROUP GROUP GROUP GROUP CO., CO., CO., CO., LTD. LTD. LTD. LTD. General General General General Pharma. Pharma. Pharma. Pharma. Factory Factory Factory Factory 20 20 20 2011 11 11 11

CTD Open Cefoperazone

Embed Size (px)

DESCRIPTION

DMF Open part

Citation preview

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    THETHETHETHE COMMONCOMMONCOMMONCOMMON TECHNICALTECHNICALTECHNICALTECHNICAL DOCUMENTDOCUMENTDOCUMENTDOCUMENT 3.2.S3.2.S3.2.S3.2.S FORFORFORFOR THETHETHETHEREGISTRATIONREGISTRATIONREGISTRATIONREGISTRATION OFOFOFOF PHARMACEUTICALSPHARMACEUTICALSPHARMACEUTICALSPHARMACEUTICALS FORFORFORFOR HUMANHUMANHUMANHUMAN USE:USE:USE:USE:

    SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    OpenOpenOpenOpen partpartpartpart

    HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTD.LTD.LTD.LTD.GeneralGeneralGeneralGeneral Pharma.Pharma.Pharma.Pharma. FactoryFactoryFactoryFactory

    2020202011111111

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.13.13.13.1 TABLETABLETABLETABLE OFOFOFOF CONTENTSCONTENTSCONTENTSCONTENTS OFOFOFOF MODULEMODULEMODULEMODULE 33333.23.23.23.2 BODYBODYBODYBODY OFOFOFOF DATADATADATADATA3.2.S DRUG SUBSTANCE3.2.S.1 General Information3.2.S.1.1 Nomenclature3.2.S.1.2 Structure3.2.S.1.3 General Properties3.2.S.2 Manufacture3.2.S.2.1 Manufacturer(s)3.2.S.2.2 Description of Manufacturing Process and Process Controls3.2.S.2.3 Control of Materials3.2.S.2.4 Control of Critical Steps and Intermediates3.2.S.2.5 Process Validation and/or Evaluation3.2.S.2.6 Manufacturing Process Development3.2.S.3 Characterization3.2.S.3.1 Elucidation of Structure and other Characteristics3.2.S.3.2 Impurities3.2.S.4 Control of Drug Substance3.2.S.4.1 Specification3.2.S.4.2 Analytical Procedures3.2.S.4.3 Validation of Analytical Procedures3.2.S.4.4 Batch Analyses3.2.S.4.5 Justification of Specification3.2.S.5 Reference Standards or Materials3.2.S.6 Container Closure System3.2.S.7 Stability3.2.S.7.1 Stability Summary and Conclusions3.2.S.7.2 Post-approval Stability Protocol and Stability Commitment3.2.S.7.3 Stability Data

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.23.23.23.2 BODYBODYBODYBODY OFOFOFOF DATADATADATADATA3.2.S3.2.S3.2.S3.2.S DRUGDRUGDRUGDRUG SUBSTANCESUBSTANCESUBSTANCESUBSTANCE3.2.S.13.2.S.13.2.S.13.2.S.1 GeneralGeneralGeneralGeneral InformationInformationInformationInformation

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.1.13.2.S.1.13.2.S.1.13.2.S.1.1 NomenclatureNomenclatureNomenclatureNomenclature

    GeneralGeneralGeneralGeneral remarkremarkremarkremarkThis Drug Master File has been compiled to provide the necessary information for the evaluationof suitability of the bulk substance of CEFOPERAZONE SODIUMmanufactured by HarbinPharmaceutical Group CoLtd

    It is used as active substance for medicinal products(dosage forms)which are blended withsulbactam sodium generally. The structure of the document represents the section 3.2.S of themodule 3 of the Common Technical Document(CTD)Thusit is appropriate to be integrated in thequality part of an application for marketing authorization

    The content of this Active Substance Master File is property of Harbin Pharmaceutical Group CoLtd. and thereforeit is confidentialThis document should not be disclosed no matter if in wholeor in part Not any parties other than customers and government employees required forregulatory purposes are authorized to have access to its content

    The manufacture of cefoperazone sodium is performed according to the presented dossier and totheGood Manufacturing Practice of the Peoples Republic of China.

    On request of relevant authorities and customers the inspection regarding the manufacture ofcefoperazone sodium is possible

    Cefoperazone sodium is an antibiotic compound of the third generation of cephaIosporins Itshows a high resistance against -lactamase And because sulbactam can strengthen theantibacterial activity of it, cefoperazone sodium has been often blended with sulbactam sodium tocomply the requirements of customers.

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    The active ingredient is commonly known under the name

    CefoCefoCefoCefoperazoneperazoneperazoneperazone sodiumsodiumsodiumsodium

    This term is used in the compendial title of the monograph of the European Pharmacopoeiapublished in its current editionThe cefoperazone sodium produced by Harbin PharmaceuticalGroup CoLtdNangang DistrictChina corresponds to the quality standard of this monograph

    ChemicaIChemicaIChemicaIChemicaI namesnamesnamesnames

    SodiumSodium(6R,7R)-7-[[(2R)-2-[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)sulphanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate.(EP 6.0)

    5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl

    -1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6 ,7 (R*)]]-.

    (USP 32)

    Sodium(6R,7R)-7-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl)acetamido-3-[[(1-methyl-H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(USP 32)

    CAS-Registry-NumberCAS-Registry-NumberCAS-Registry-NumberCAS-Registry-Number

    [62893-20-3]

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.1.23.2.S.1.23.2.S.1.23.2.S.1.2 StructureStructureStructureStructure

    The chemical structure of cefoperazone sodium is exhibited below.

    CefoCefoCefoCefoperazoneperazoneperazoneperazone sodiumsodiumsodiumsodium

    MolecularMolecularMolecularMolecular formulaformulaformulaformula

    C25H26N9NaO8S2

    RelativeRelativeRelativeRelative molecularmolecularmolecularmolecular massmassmassmass

    668

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.1.33.2.S.1.33.2.S.1.33.2.S.1.3 GeneralGeneralGeneralGeneral PropertiesPropertiesPropertiesProperties

    AppearanceAppearanceAppearanceAppearanceA white or slightly yellow powder

    HygroscopicityHygroscopicityHygroscopicityHygroscopicityHygroscopic

    pkpkpkpkaaaa-value-value-value-valueThe pH of the solution is 4.5 to 6.5.

    InfraredInfraredInfraredInfrared absorptionabsorptionabsorptionabsorption spectrophotometryspectrophotometryspectrophotometryspectrophotometryExamine by infrared absorption spectrophotometry (2.2.24), comparing with the Ph. Eur. referencespectrum of cefoperazone sodium.

    SolubilitySolubilitySolubilitySolubilityFreely soluble, in water, soluble in methanol, slightly soluble in alcohol.

    PolymorphismPolymorphismPolymorphismPolymorphismIf crystalline, it shows polymorphism.

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.23.2.S.23.2.S.23.2.S.2 ManufactureManufactureManufactureManufacture

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.2.13.2.S.2.13.2.S.2.13.2.S.2.1 Manufacturer(s)Manufacturer(s)Manufacturer(s)Manufacturer(s)

    The name and address of the manufacturing site of the active ingredient manufacturer is:

    HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTD.LTD.LTD.LTD. GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    No. 109 Xuefu RoadNangang Dist.Harbin, Peoples Republic of China

    Tel: 0086-0451-86665134Fax: 0086-0451-86662959E-mail: [email protected]

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.2.23.2.S.2.23.2.S.2.23.2.S.2.2 DescriptionDescriptionDescriptionDescription ofofofof ManufacturingManufacturingManufacturingManufacturing ProcessProcessProcessProcess andandandand ProcessProcessProcessProcess ControlsControlsControlsControls

    A.A.A.A. SyntheticSyntheticSyntheticSynthetic routerouterouteroute

    CefoperazoneCefoperazoneCefoperazoneCefoperazone acidacidacidacid

    PreparationPreparationPreparationPreparation ofofofof TZATZATZATZA

    DissolveDissolveDissolveDissolve ofofofof TZATZATZATZA

    NN

    NS

    N

    CH3S

    NH2N

    OCOOSi(CH3)3

    CH2CH3CN

    BSACH2

    COOHO

    H2NN

    S CH3

    NNS

    NN

    AcylAcylAcylAcyl chloridechloridechloridechloride reactionreactionreactionreaction

    AcylationAcylationAcylationAcylation

    COCl

    OH

    CHNHCO

    C2H5

    O O

    N N

    CH2COOSi(CH3)3

    O

    H2NN

    S CH3

    NNS

    NN

    +

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    CH3C

    OC NH CH

    OH

    O O

    NC2H5 N

    COOSi(CH3)3

    HHO

    NN

    NSCH2

    S

    O NN

    N

    hydrolysishydrolysishydrolysishydrolysis

    NC2H5 N

    OO

    OH

    CHNHCO

    CCH3

    NN

    NO

    S

    CH2 SN

    NN

    O HH

    COOSi(CH3)3

    H2O

    HHO

    NN

    NSCH2

    S

    O NN

    N

    CH3C

    OC NH CH

    OH

    O O

    NC2H5 N

    COOH

    CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.2.33.2.S.2.33.2.S.2.33.2.S.2.3 ControlControlControlControl ofofofof MaterialsMaterialsMaterialsMaterials

    In the following starting materials will be presented which are mentioned in the description of themanufacturing process in section 3.2.S.2.2:

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    AAAAcetonitrilecetonitrilecetonitrilecetonitrile

    MolecularMolecularMolecularMolecular formulaformulaformulaformula:::: CH3CNMolecularMolecularMolecularMolecular weightweightweightweight:::: 41.05

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    BFBFBFBF3333-Acetonitrile-Acetonitrile-Acetonitrile-Acetonitrile

    MolecularMolecularMolecularMolecular formulaformulaformulaformula:::: C 2H3NBF 3MolecularMolecularMolecularMolecular weightweightweightweight:::: 109Structure:Structure:Structure:Structure:

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    5-mercapto-1-methyltetrazole5-mercapto-1-methyltetrazole5-mercapto-1-methyltetrazole5-mercapto-1-methyltetrazole

    MolecularMolecularMolecularMolecular formulaformulaformulaformula:::: C2H4N4SMolecularMolecularMolecularMolecular weightweightweightweight:::: 116.14Structure:Structure:Structure:Structure:

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    7-ACA7-ACA7-ACA7-ACA

    MolecularMolecularMolecularMolecular formulaformulaformulaformula:::: C 10H 12N 2O 5SMolecularMolecularMolecularMolecular weightweightweightweight:::: 272.27Structure:Structure:Structure:Structure:

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    AmmoniaAmmoniaAmmoniaAmmonia WaterWaterWaterWater (refined)(refined)(refined)(refined)

    MolecularMolecularMolecularMolecular formula:formula:formula:formula: NH4OH or NH3 H2OMolecularMolecularMolecularMolecular weight:weight:weight:weight: 35.10

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    AcetoneAcetoneAcetoneAcetone

    MolecularMolecularMolecularMolecular formulaformulaformulaformula: C3H6OMolecularMolecularMolecularMolecular weightweightweightweight: 58.08StructureStructureStructureStructure:

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    6%6%6%6% sulfuroussulfuroussulfuroussulfurous acidacidacidacid

    MolecularMolecularMolecularMolecular formulaformulaformulaformula: H2SO3MolecularMolecularMolecularMolecular weightweightweightweight: 82.08

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    N,O-Bis(trimethylsilyl)acetamideN,O-Bis(trimethylsilyl)acetamideN,O-Bis(trimethylsilyl)acetamideN,O-Bis(trimethylsilyl)acetamide (BSA)(BSA)(BSA)(BSA)

    MolecularMolecularMolecularMolecular formulaformulaformulaformula: C8H21NOSi2MolecularMolecularMolecularMolecular weightweightweightweight: 203.43StructureStructureStructureStructure:

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    DimethylacetamideDimethylacetamideDimethylacetamideDimethylacetamide ((((DMAC)DMAC)DMAC)DMAC)

    MolecularMolecularMolecularMolecular formulaformulaformulaformula: CH3CON(CH3)2MolecularMolecularMolecularMolecular weightweightweightweight: 87.12StructureStructureStructureStructure:

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    PPPPhosphorushosphorushosphorushosphorus oxychlorideoxychlorideoxychlorideoxychloride

    MolecularMolecularMolecularMolecular formulaformulaformulaformula: POCl3MolecularMolecularMolecularMolecular weightweightweightweight: 153.33

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    ActiveActiveActiveActive carboncarboncarboncarbon #767#767#767#767

    MolecularMolecularMolecularMolecular formula:formula:formula:formula: CMolecularMolecularMolecularMolecular weight:weight:weight:weight: 12.01

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    SodiumSodiumSodiumSodium BicarbonateBicarbonateBicarbonateBicarbonate

    MolecularMolecularMolecularMolecular formula:formula:formula:formula: NaHCO3MolecularMolecularMolecularMolecular weight:weight:weight:weight: 84.01

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.2.43.2.S.2.43.2.S.2.43.2.S.2.4 ControlsControlsControlsControls ofofofof CriticalCriticalCriticalCritical StepsStepsStepsSteps andandandand IntermediatesIntermediatesIntermediatesIntermediates

    With reference to section 3.2.S.2.2 it is obvious from the description of the manufacturingprocess that during this process cefoperazone acid, as an isolated intermediate, isobtained. This cefoerazone acid is still nonsterile. For this reason a separateinprocess control of the key intermediate cefoperazone acid takes place and theanalytical tests are described. The reasonable inprocess specification ensures that thefinished active substance meets the specification.

    PreparationPreparationPreparationPreparation ofofofof TZATZATZATZA

    ProcessProcessProcessProcess ControlControlControlControl pointpointpointpoint SpecificationSpecificationSpecificationSpecification TreatmentTreatmentTreatmentTreatment

    Condensationreaction

    Temperature 121 Control thetemperature

    Assay of 7-ACAafter reaction.

    < 2.0 mg/ml

    CrystallizationpH 3.1 ~ 3.3

    Control usingammonia water

    Temperature 91 Control thetemperature

    CefoperazoneCefoperazoneCefoperazoneCefoperazone acidacidacidacid

    ProcessProcessProcessProcess ControlControlControlControl pointpointpointpoint SpecificationSpecificationSpecificationSpecification TreatmentTreatmentTreatmentTreatment

    Dissolve of TZA Temperature 20 ~23 Control using hot

    waterAcyl chloridereaction

    Temperature -25 ~ -30 Control using liquid

    nitrogen

    AcylationTemperature -302

    Control using liquidnitrogen

    Assay of TZA afteracylation.

    < 2 %

    Crystallization

    Assay ofCefoperazone

    side-chain acid < 3mg/ml after

    crystallization.

    < 3.0 mg/ml

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    ProcessProcessProcessProcess ControlControlControlControl pointpointpointpoint SpecificationSpecificationSpecificationSpecification TreatmentTreatmentTreatmentTreatment

    Forming sodiumsalt reaction

    Temperature

    pH

    20 ~ 25

    6.0 ~ 7.0

    Control the temperatureusing ethylene glycol inmezzanine.Adjust using NaHCO3slowly.

    Crystallization Temperature

    How long the acetone dropping

    26 2

    For 4.5 hours

    Control the temperatureusing ethylene glycol inmezzanine.

    Centrifugalizationand washing

    Turns when transfer crystallizationsolutionTurns when add washing solutionTurns when centrifugalization

    600 50 rpm

    600 50 rpm900 300 rpm

    Adjust the turns permins.

    Drying TemperatureWater

    60 2 Hot water circulationEvacuate during drying

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.2.53.2.S.2.53.2.S.2.53.2.S.2.5 ProcessProcessProcessProcess ValidationValidationValidationValidation and/orand/orand/orand/or EvaluationEvaluationEvaluationEvaluation

    Documentation on process validation is given in the Restricted Part of the ActiveSubstance Master File and is submitted directly to registration authorities on request.

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.2.63.2.S.2.63.2.S.2.63.2.S.2.6 ManufacturingManufacturingManufacturingManufacturing ProcessProcessProcessProcess DevelopmentDevelopmentDevelopmentDevelopment

    Not applicable.

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.33.2.S.33.2.S.33.2.S.3 CharacterizationCharacterizationCharacterizationCharacterization

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.2.S.3.13.2.S.3.13.2.S.3.13.2.S.3.1 ElucidationElucidationElucidationElucidation ofofofof StructureStructureStructureStructure andandandand otherotherotherother CharacteristicsCharacteristicsCharacteristicsCharacteristicsChemicalChemicalChemicalChemical structurestructurestructurestructure analysisanalysisanalysisanalysis ofofofof CefoperazoneCefoperazoneCefoperazoneCefoperazone sodiumsodiumsodiumsodium

    I.I.I.I. NameNameNameName ofofofof compoundcompoundcompoundcompound

    Drug name (English): Cefoperazone Sodium

    Chemical name (English):

    Sodium

    (6R,7R)-3-[[(1-methyl-H-tetrazol-5-yl)thio]methyl]-7-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxa

    mido)-2-(phydroxy phenyl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-carboxylate

    II.II.II.II. MolecularMolecularMolecularMolecular formulaformulaformulaformula andandandand molecularmolecularmolecularmolecular weightweightweightweight andandandand chemicalchemicalchemicalchemical structurestructurestructurestructure formulaformulaformulaformula

    Molecular formula: C25H26N9NaO8S2

    Molecular weight: 667.66

    Structure formula:

    III.III.III.III. UltraviletUltraviletUltraviletUltravilet absorptionabsorptionabsorptionabsorption spectrumspectrumspectrumspectrum

    Apparatus:Cary 1E violet-visible spectrophotometer,America

    Conditions:With 10g/ml and 12g/ml of test solution concentration respectively and 190-600nm

    of scanning width.

    1.1.1.1. UltravioletUltravioletUltravioletUltraviolet absorptionabsorptionabsorptionabsorption spectrumspectrumspectrumspectrum

    a.Ultraviolet absorption spectrum of RS

    b.Ultraviolet absorption spectrum of test sample

    2.Ultraviolet2.Ultraviolet2.Ultraviolet2.Ultraviolet absorptionabsorptionabsorptionabsorption spectrumspectrumspectrumspectrum datadatadatadata ofofofof referencereferencereferencereference standardstandardstandardstandard

    For methanol solution,1=200, 2=229,3=269

    3.3.3.3. UltravioletUltravioletUltravioletUltraviolet absorptionabsorptionabsorptionabsorption spectrumspectrumspectrumspectrum datadatadatadata ofofofof testtesttesttest samplesamplesamplesample

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    For methanol solution,1=200, 2=229,3=269

    4.Conclusion:4.Conclusion:4.Conclusion:4.Conclusion: There exists -* and n-* band absorption in UV,which shows that the

    compound contains the structure replacing the phenyl and carbonyl.

    IV.ElementsIV.ElementsIV.ElementsIV.Elements analysisanalysisanalysisanalysis

    Apparatus model:EA 1112E element analyzer,Flash company,Italia.

    Test condition:Left oven temperature of reactor:950 C;Right oven temperature of reactor:

    22C;Gas:High purity He and O2;Chromatographic column temperature: 75C.

    Test data list of test sample:

    Theoretical value Test value

    Test I Test II Test III

    C%H%N%S%

    44.973.9318.889.61

    43.374.2718.769.23

    43.414.3318.729.41

    43.394.3018.749.32

    V.V.V.V. InfraredInfraredInfraredInfrared absorptionabsorptionabsorptionabsorption spectrum(IR)spectrum(IR)spectrum(IR)spectrum(IR)

    Apparatus model:FTS-135 Fourier transform infrared spectrometer,BIO-RAD company,America.

    Test condition:Adopt KBr pellet method

    1.Infrared1.Infrared1.Infrared1.Infrared spectrogramspectrogramspectrogramspectrogram

    a. Infrared spectrogram of RS

    b.Infrared spectrum of test sample

    2.2.2.2. InfraredInfraredInfraredInfrared spectrumspectrumspectrumspectrum testtesttesttest datadatadatadata tabletabletabletable ofofofof testtesttesttest samplesamplesamplesample

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    Note:strength: vs: extremely strong,s:strong,m:medium,w:weak

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    3.3.3.3. IRIRIRIR SpectrumSpectrumSpectrumSpectrum analysisanalysisanalysisanalysis

    a.Wide and strong absorption centered at ~3400cm-1 is originated from OH stretching

    vibration;Strong absorption entrapped in low wave number side of 1610 cm-1 and 1514cm-1 is

    originated from benzene ring vibration(Vring);The OH changing angular vibration at 1365cm-1 and

    C-O stretching vibration at 1174cm-1 is originated from phenol;The absorption at 841cm-1 is

    originated from outside changing angular viabration of C-H side.All these data show that there

    exists structure in the molecule.

    b.Wide and strong absorption at 3287 cm-1 is originated from NH stretching

    vibration(vNH);1680cm-1 is originated from amid I band;Absorption entrapped in 1514cm-1 is

    originated from absorption on amid II band;Amid III band is at 1282cm-1 ;806cm-1 and 753cm-1 is

    originated separately from amid V band and IV band;576cm-1 is originated from amid VI

    band.Appearance of all these bands is connective with the amid structure .

    c.Stretching virbration with high wave number C=O(vC=O) appearing at 1762 cm-1 is

    characterization of structure.

    d.1716cm-1 and 1670cm-1 (entrapped in the low wave number side of 1610 cm-1)is separatedly

    originated from stretching vibration of two carbonyls in structure ,together considering

    that characteristic vibration of CH2-CH2- appears at 753cm-1 and CH stretching vibration

    (vas CH2)of CH2 at 2940cm-1 and changing angular vibration of CH2 at 1463cm-1 ,all these prove

    that there exists structure in the molecule.

    e.Addtionally,absorption band at 1610cm-1 involves N=N stretching vibration,while

    1514cm-1 ,1365cm-1 ,1282cm-1 and 1109cm-1 is originated from stretching vibration of

    ring,showing that there exists this structure in the molecule.697cm-1 and 618cm-1

    can be classified as C-S stretching vibration,which is consistent with CH2-S- and

    structure .

    f.Absorption about at 1540cm-1 entrapped in the high frequency side of 1514cm-1 js

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    antisymmetry stretching vibration of carboxylic radical COO-(vas COO-).Together with the

    symmetry stretching vibration(vas COO-)at 1392cm-1 ,all these prove there exists carboxylic

    radical conjugating with C=C in the molecule.

    g.IR spectrum of the test sample is consistent with that of the reference standard.

    VI.VI.VI.VI.1111HHHH NMRNMRNMRNMR

    Apparatus: Unity-400 nuclear magnetic resonance spectrometer,Varian,America.

    Solvent:Deuterated dimethyl sulfoxide DMSO-d6 , standard reference

    displacement:TMS=0.00;heavy water(D2O),reference displacementD20=4.7

    i.i.i.i. One-dimensionalOne-dimensionalOne-dimensionalOne-dimensional 1111HHHH NMRNMRNMRNMR testtesttesttest

    1. One-dimensional 1H NMR test

    a. 1H NMR spectrum of reference standard

    b. Heavy water exchange 1H NMR spectrogram of reference standard

    c. 1H NMR spectrum of test sample

    d. Heavy water exchange 1H NMR spectrogram of test sample

    2. 1H NMR test data table of test sampleSerial no. ofpeak

    Chemical shift

    Multiplicity Couplingconstant(Hz)

    Protonnumber

    Correspondingproton

    12345678910111213

    9.939.729.307.206.745.565.514.874.414.213.913.71-3.321.08

    bsddddddddddsmt

    6.88.07.88.06.8,4.47.24.412.012.0

    7.2

    1112211111383

    -OH>NH>CH=CH-=CH->CH->CH->CH--CH2--CH2--CH3-CH2--CH3

    ii.ii.ii.ii. Two-dimensionalTwo-dimensionalTwo-dimensionalTwo-dimensional 1111H-H-H-H-1111HHHH correlatedcorrelatedcorrelatedcorrelated NMRNMRNMRNMR test(test(test(test(1111H-H-H-H-1111HHHH COSY)COSY)COSY)COSY)

    1.Two-dimensional 1H-1H correlated NMR spectrogram of reference standard

    2. Two-dimensional 1H-1H correlated NMR spectrogram of test sample

    3. Two-dimensional 1H-1H correlated NMR test data table of test sample

    Serial no. Chemical shift Correlated peak shift

    Crossing peak intensity

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    12345678910

    9.729.307.206.745.565.514.414.213.371.08

    5.515.566.747.209.309.724.214.411.083.37

    mwsswmssss

    iii.iii.iii.iii. ProtonProtonProtonProton NMRNMRNMRNMR spectrumspectrumspectrumspectrum analysisanalysisanalysisanalysis ofofofof testtesttesttest samplesamplesamplesample

    1. For 26 protons observed in the 1H NMR spectrum of DMSO-d6 solvent of this product,three

    groups of peak at low field will disappear in heavy water,the other peak will become wider

    apparently and part of them have shifted. The amount and type of hydrogen atom of the

    test sample is consistent with that of the chemical structural formula of Cefoperazone sodium.

    2. 9.72 and9.30 at low field is separately weakly coupled with5.51 and5.53 in COSY

    spectrum,with the coupling constant separately being 6.8Hz and 8.0Hz,but they will disappear

    in the heavy water spectrum.Obviously,the two above-mentioned peaks belong to NH3,which

    shows that there exist NHCH structure in this compound.

    3. Both7.20 and6.74 belong to d desintegration,and JHH equals to 8Hz.Both peaks correspond

    to 2 protons,which produce strong coupling information in COSY spectrum and belong to para

    substitution benzene proton contribution.

    4. 1.08 at high field corresponds to 3 proton contribution,and belongs to triple

    disintegration,which produces coupling information with 3.37 in COSY spectrum and

    belongs to CH3 proton contribution.All these show that there exist CH2CH3 structure. 3.91 is

    a single peak and its signal strength corresponds to 3 proton resonance,which falls within

    lowest field and belongs to NCH3 proton contribution.

    5. Two groups of peaks of 4.41 and4.21 constitute d disintegration with same coupling

    constant,which produce strong coupling information in COSY spectrum.The two groups of

    peaks constitute quadri peaks which show high inside and low outside,and is represented as

    typical AB self-rotating system.

    6. 1H NMR spectrum of the test sample is consistent with that of the reference standard.

    VII.VII.VII.VII.13131313CCCC NMRNMRNMRNMR

    Apparatus: Unity-400 nuclear magnetic resonance spectrometer

  • HARBINHARBINHARBINHARBIN PHARMACEUTICALPHARMACEUTICALPHARMACEUTICALPHARMACEUTICAL GROUPGROUPGROUPGROUP CO.,CO.,CO.,CO., LTDLTDLTDLTD GeneralGeneralGeneralGeneral Pharm.Pharm.Pharm.Pharm. FactoryFactoryFactoryFactory

    CTDCTDCTDCTD ModuleModuleModuleModule 3.2.S3.2.S3.2.S3.2.S forforforfor SterileSterileSterileSterile CefoperazoneCefoperazoneCefoperazoneCefoperazone SodiumSodiumSodiumSodium

    Solvent:Deuterated water(D2O), reference standard:DMSO=39.5

    i.i.i.i. One-dimensionalOne-dimensionalOne-dimensionalOne-dimensional 13131313CCCC NMRNMRNMRNMR testtesttesttest

    1. One-dimensional 13C NMR test

    a.13C NNE NMR spectrum of reference standard

    b. 13C DEPT NMR spectrum of reference standard

    c. 13C NNE NMR spectrum of test sample

    d. 13C DEPT NMR spectrum of test sample

    2.13C NMR test data table of test sample

    Serial no. ofpeak

    Chemical shift Multiplicity Amount of C Correponding type of C

    12345678910111213141516171819202122

    171.28166.53163.25159.03155.78155.67153.04151.94129.81127.85126.68117.62115.0457.8457.0356.6042.3439.7035.4733.1425.7010.44

    sssssssssdssddddtttqtq

    1111111112112111211111

    >C=O=CC=O>C=O>C=O>C=O>C=O=C